BioTech Navigator Investment Newsletter 01 01 News Color Page 8
8
Bio Stocks Pool
List of companies who are developing therapeutics for wound healing.
8
BioTech Sage Report, January 2001
Symbol
52 Wk
52 Wk
Price
M
arket
E
arnings
P
er
S
hare
Product
Clinical
Advanced Tissue
ATIS
NA
16.00
2.5
3.03
194.5M
-
.45 NA
DermaGraft
Diabetic foot ulcers
NDA
Aventis
Pharmaceuticals
AVE
NA
84.56
45.50
85.00
66.3B
-
2.51 NA
Albuminar
-
25
Albuminar
-
5
Wound/ulcer healing
Wound/ulcer healing
Market
Market
Cellegy
CLGY
NA
10.56
3.06
5.50
75.8M
-
.85
-
.93
Anogesic
Wound/ulcer healing
Phase III
Closure Medical
Corp
CLSR
NA
36.81
12.25
35.25
472.8M
-
.19
-
.13
Dermabond
TraumaSeal
Wound closure
Market
Chiron
CHIR
51.2
71.00
33.06
45.00
862.0B
.86 .88
rFGF
-
2
Severe coronary artery
disease
Phase II
Connetics Corp.
CNCT
NA
28.75
4.00
4.63
136.8M
-
1.21
-
.50
Relaxin
Non
-
healing ulcers
Preclinical
Curis Inc.
CRIS
NA
27.25
6.88
8.50
221.9M
NA NA
OP
-
1 Implant
Non healing
-
fractures
Fresh fractures
Spinal Fusion
PA
Phase III
Phase II
Genzyme
Biosurgery
GZBX
NA
11.75
8.63
8.75
NA
NA NA
TGF
-
Beta 3
Carticel
Wound healing
Cartilage
Osteoarthritis
Phase I
Market
Geron
GERN
NA
75.88
11.25
15.44
335.4M
-
3.00 NA
Regenerative medicine
Neural, liver, heart and skin
Research
Gliatech
GLIA
NA
27.69
3.75
4.06
39.2M
-
.04 .0
Adcon
-
T/N
Prevents adhension
Market
Human Genome
Sciences
HGSI
NA
116.38
25.00
68.56
8.27B
-
.46
-
1.02
Repifermin
Venous ulcers
Mucositis
Phase II
Incara
Pharmaceuticals
INCR
NA
11.00
.88
2.13
15.7M
-
1.06 NA
Precursor cell tran
s-
Liver transplants
P
reclinical
